Topic Archives: Tesla Motors (TSLA)

This article was originally published on December 1, 2020, but we’re seeing new versions with different headlines and that “March 2021” deadline, so we’re re-publishing our comments below. What follows has not been updated or revised in the past month. Lou Basenese is pitching Elon Musk’s next big idea in ads for his Trend Trader […]

I’ve written about a bunch of “pre-IPO” investments in the past, but Ian Wyatt has probably been more relentless than anyone else in promoting this idea of “buying in before it’s public” … particularly when it comes to the hot “brand names” that excite investors. Wyatt’s latest pitch is for a “webinar” that will air […]

This article was originally published on April 23, 2020, when we first saw the ads from Paul Mampilly — most recently this has been more aggressively pitched with the idea of the “12 million mile battery,” so we’re re-posting our solution for you.  The ad has not changed and is still dated April 2020, and […]

The first version of this article ran way back on March 30, 2016, so it might look familiar to a lot of you — but a few folks asked about it today, and it looks like the ad is running again, still without much change to the spiel, so I’m re-publishing this teaser solution. I’ve […]

The talk of trade war with China is bringing the idea of Chinese mineral dominance back to the pages of investment teaser ads… we’ve seen several in the last week or two that focus on rare earths, where China remains dominant and might have some extra negotiating leverage in trade disputes, and this latest pitch […]

Jason Stutman’s “upgrade” newsletter, The Cutting Edge ($1,499/yr), is out with a teaser campaign that promises you the chance at riches from “Charged Ore” … and, in fact, an actual sample of that ore itself as part of your subscription. So what is “Charged Ore,” and what’s this little Nebraska mine that Stutman thinks will […]

Several readers have asked me this week what “Dividend Superstations” are… so that’s the target for the Thinkolator today. The ad comes from Brett Owens for his Contrarian Income Report, which is usually sold as a service that looks for a “secure 8% ‘no withdrawal’ return” for retirement — an admirable goal, and not terribly […]

Ian Wyatt is out with a new teaser promo for his $100K Portfolio service, and it’s all about a young company that’s growing rapidly and changing America in a substantial way … with a free new “highway” across the country. He pitches this secret stock using the same kind of language that several other growth-focused […]

I wrote about Hilary Kramer and her new(ish) GameChangers newsletter for the first time just a couple weeks ago — so it’s certainly too early to judge whether her teaser stocks tend to perform as she predicts (that pick, Metalico, is down about 10% from when I wrote about it … but I don’t hold […]

Comments

  • Avatar

    I am a paid up..expensive user.. I would like to say it is great so others can face the same drain of capital. Same o...

  • Avatar

    I signed up for the Zacks home study (including Research Wizard) course & paid a small fee for this. In using this ...

  • Avatar

    I'm considering a lifetime membership with Zacks, so if theres any feedback from anyone on Zacks it would be much apprec...

  • Avatar

    Whether DOMO is Mampilly’s teased company or not, I found three recent articles (March & April 2019) highly recommendi...

  • Avatar

    I subscribed to Zacks service and for my $350 for a year I got the lower end portfolio info, under 10, home run, etc.. ...

  • Avatar

    Here's a current Zacks report that will provide more clarity: http://s1.q4cdn.com/460208960/files/News/2017/Dec-20-2017...

  • Avatar

    Does anyone have any feedback on using Zacks Research Wizard software as a lifetime member? If so have long have you use...

  • Avatar

    bunion, He could do that but then he could also be sued. You may not reproduce, retransmit, disseminate, sell, publi...

  • Avatar

    I've seen nothing but mediocrity out of Zacks, so I don't understand at all where you are coming from. GT recommended A...

  • Avatar

    If you like spending your time watching videos and listening to Andy upsell all his financial buddies, buy his outragiou...

  • Avatar

    Alteryx (AYX) has been on Zacks specialty service radar as recently as Q4 2018....

  • Avatar

    Travis, can you research Zacks Weekly Black Box and advise...

  • Avatar

    Dear Travis and/or Irregulars, Would any of you know or be willing to share Zack's "Top 10 Stocks for 2019"? No matter ...

  • Avatar

    I second all that you said. PM is so much more comprehensive and I always learn something every time he sends his podcas...

  • Avatar

    Left identified INGN as his next short target, May 24 when it was at 170. It momentarily dropped to 157 but then went o...

  • Jay Ram

    I think new investors can learn a lot from learning how Zack's (and similar ratings firms) generate their ratings, and a...

  • Avatar

    More of a general question but how accurate do you find the zacks rankings when looking at whether to buy or sell stocks...

  • Avatar

    $DMCAF STROKE DiaMedica Therapeutics Like $ARTH I believe $DMCAF is a derisked situation that I believe there coul...

  • Avatar

    I have an account with interactive brokers through Zacks Trade Pro. Tried to buy CSE: XMG, MGX Minerals. A warning indi...

  • Avatar

    Zacks has OLED with an underperform rating, as does Columbine Capital Services, ValuEngine and Institutional Shareholder...

  • Avatar

    Okay, so this was back in January. I bought a little TTD back in March and it's up 71% since then, much more than anyth...

  • Avatar

    Whoo boy,ya gotta have some big brass ones to start monkeying around with junk bonds, or even anything BBB rated these d...

  • Avatar

    $APTO 5/24/18 FROM https://www.thelincolnianonline.com/2018/05/24/aptose-biosciences-apto-sees-large-volume-increase.ht...

  • Avatar

    Sounds like you feel aboutBlanco the way I feel about Zack’s – whatever they recommend, do the opposite. Luckily on...

  • Avatar

    Recently read Zack's book on stock screeners and was wondering if there are any fundamental indicators that you consiste...

  • Avatar

    Zacks stock services is always teasing their highly rated stock pics - and for exorbitant fees. Have you investigated t...

  • Avatar

    Travis regarding your comment above on the NVDA analyst average 'buy' target of $236. Below is a chart from Zacks Commen...

  • Avatar

    I subscribed to the Research Wizard a couple years ago. I use their recommendations from the different strategies. I use...

  • Avatar

    Seems as if The Chemours Company (CC) has attracted some attention lately. Apart for Louis Navalier (who will pitch anyt...

  • Avatar

    The folks at ValuEngine must be the most astute analysts in the business based upon this "upgrade"? Aptose Biosciences ...

  • Avatar

    Zack's rank 4B (sell)...

  • Travis Johnson, Stock Gumshoe

    Thanks for the feedback — Zacks is mostly a quantitative system, similar to Navellier or Cabot, so they pretty much ne...

  • Avatar
  • Avatar

    did you see DQ was upgraded to buv by zacks analysts last night and on 24/01 Navellier associates purchased 29,400 share...

  • Avatar

    $SNDX long In case people were wondering about a nice bit of upward movement in SNDX today, there was a Zacks note fr...

  • Avatar

    $MEIP Long - I have no options on phase 3 drug candidate but I share what I found of interest recently: minimal inside o...

  • SoGiAm

    $MICT np - Micronet Enertec Technologies Signs Definitive Agreement to Sell its Defense and Aerospace Subsidiary, Ene...

  • SoGiAm

    $DXC - Wild ride https://finviz.com/quote.ashx?t=dxc #TIDAL ;-) Jan-02-18 07:38AM Zacks.com highlights: Estee Lauder...

  • SoGiAm

    $CWBR xxowxx - If any one knows of an analyst or five, please have them write a report, a blog or two and rub elbows wit...

  • Avatar

    $zacks Certainly looks like KSS has caught on in Zacksland. They traffic primarily in earnings derived metrics, and b...

  • Avatar

    It looks Like Zacks analysts are Dr. KSS fans!...

  • Avatar

    $VRNA Zacks: Brokerages Set $26.75 Target Price for Verona Pharma PLC American Depositary Share (VRNA) Dec 5, 2017 Cur...

  • Avatar

    I just viewed Chucks 45 min videos showing deep ITM options and his strategy of locking in a 30% profit with an ATM put ...

  • Avatar

    Did you ever take the plunge with Zack's Research Wizard? How is it doing?...

  • Avatar

    $ONOV $Zacktrades trade problem update: I received an email from Zack's apologizing for the confusion. As expected, li...

  • Avatar

    $ONOV Clearly, if Zacks cannot make limit orders of OTC stocks, they are in my rear view mirror. They indicated quite c...

  • Avatar

    If it is the market maker then that should apply to all brokers methinks. I would leave Zacks over such a practice mysel...

  • Avatar

    $ONOV small position Has anyone had any problems trading this stock? I have a small amount in an account at Zacks and t...

  • Avatar

    Zacks throws out a huge load of trades, but isn't very good at mathematics after that....

  • Avatar

    My experience with Oxford has not been positive. Trying to get $ back. Better off with Zacks and doing some dd....

  • Avatar

    Thank you Travis - much appreciated. I wonder why Zacks won't find CWBR....

  • Avatar

    This is pretty great material. Getting late. Defiantly have to do more research on EV's and get some positions in this m...

  • SoGiAm

    $MRTX np - Zacks has a 3, Hold recommendation. Tipranks has average price target of $11.67. https://www.tipranks.com/...

  • Avatar

    $RGLS Zacks upgrades Regulus to BUY this morning. The firm's current PT= $1.25 https://www.themarketsdaily.com/201...

  • Avatar

    Zack's #2 buy, Nutanix Inc. (NTNX)(Delayed Data from NSDQ) $21.56 USD September 15,2017 4:00 PM -0.05 (-0.23%) Look at...

  • Avatar

    I am a fairly new subscriber to Stock Gumshoe, really am impressed with the knowledge of so many investors here. My que...

  • Avatar

    Read all you can free on the web virtual magazine's. Good one's are Nasdaq, Motley Fool, Zack's, Seeking Alpha, The Str...

  • Avatar

    $PTGX "Brokerages Set $29.67 Price Target for Protagonist Therapeutics, Inc. (PTGX)" Monday, August 28th, 2017 ...

  • Avatar

    CBI is now down around the $10 mark. Zacks have marked it as the Bear of the Day. The long term tend is down down dow...

  • Avatar

    Automated scam. The fact they hide their $499 annual price and offer free deal and more deal. Just makes it non-trust wo...

  • Avatar

    I'm enjoying success with Zacks Under $10 Portfolio....

  • Avatar

    All of the investing world ignores Zack's computer-generated articles, and I believe we should do the same....

  • Avatar

    $RXDX RXDX listed as 1 of 4 "Sell-Ranked Drug Stocks to Avoid Ahead of Q2 Earnings".... I've had a partial position sin...

  • Avatar

    I recently "sat" through one of the Fool's long, drawn-out come-ons ... three years for $159 for their incredible advice...

  • Avatar

    Glad I stopped by, I too keep receiving emails so I sat thru the long video and it was just a another to good to be true...

  • AC/DC

    $ARTH Price targets from different firms from that article are: Roth Captial: $3.00 Zacks Investment Research: $0...

  • Avatar

    The only kernel you will find in any of these email based, internet pitches is at the end of the day you are wasting you...

  • Avatar

    Zacks is usually late; I ignore them....

  • Avatar

    ARTH long old news Zacks Investment Research, Inc. upgrades ARCH THERAPEUTICS COM USD0.001 from HOLD to BUY...

  • Avatar

    Hi, Bill just a little bit of my style of investing. I never mess with options. I study stocks at as low as $.89 to $50...

  • Avatar

    Zacks had Amazon as a strong sell a month ago. Now it's 50 points higher....

  • Avatar

    Shop is a zacks strong sell....

  • Avatar

    $GNMX: SAGA Misses Primary Endpoint But Data Warrants Optimism Zacks Small Cap Research March 28, 2017 http://s...

  • DrKSSMDPhD

    Zacks is a contrarian indicator...

  • Avatar

    Long $RGLS The Zacks Investment Research Lowers Regulus Therapeutics Inc ($RGLS) to Sell and $RGLS up +0.20 (16.00%)...

  • DrKSSMDPhD

    Hi Sam: Still pretty hard for me to enthuse about $CBAY when the market offers an absolute embarrassment of scientifi...

  • Avatar

    Chip actually has it right. $AMAG (np) pre-announced their earnings today, lowering their guidance. It was below t...

  • Avatar

    That is just Zacks estimated earnings revision for $AMAG. Very misleading postings Chip12; AMAG has not revised its ear...

  • Avatar

    BTW - Zack's Research just put #PTN on "hold". I think this is a good sign to add to my position. jokin...

  • SoGiAm

    MarketBeatCom ‏@RatingsNetwork Karyopharm Therapeutics downgraded by Zacks Investment Research to hold. $KPTI np ...

  • Avatar

    On May 12,2016 STM was $5.34, Reached a High of $9.45. That's a profit of $4.10 per share in 6 months. I let the results...

  • SoGiAm

    November 7, 2016 Chart: Polls for marijuana measures tight heading into Election Day http://mjbizdaily.com/wp-conten...

  • Avatar

    You'd be hard-pressed to find a broker who would make a portfolio of that quality for that price, is what I intended to ...

  • Anamorph

    Reuters are not an investment banking or brokerage firm and don't do analysis. They are a news service and have, like y...

  • Avatar

    Thanks HN. What are your few recommendations that I should buy. There are so many out there that I don't know what to do...

  • Avatar

    Art, if you got in around $3.50 and it is $5.80 as I write, your golden. It will continue to run up to PUDFA on 14th. M...

  • JohnM

    I'm pretty sure this is a computer-written site. TheStreet.com does a lot of this, and so does Zack's. As Anamotph said,...

  • Avatar

    Welcome PMB. Regarding $SCYX share price, I am sure you know that bio stocks are extremely volatile, especially small ca...

  • Avatar

    The latest re: $STEM StemCells Inc. (NASDAQ:STEM) Receives Consensus Recommendation of “Buy” from Brokerages P...

  • Avatar

    I do my own homework turning $750 into $400k since 1986. Sure you lose some but it was my own fault leaving the guidelin...

  • Avatar

    Also, for those who are skeptical about the TRXC stock price, don't forget that: "Brokerage Recommendations: Accor...

  • Avatar

    I often check finance.google.com to check for news on stocks and invariably find a bunch of me-too type 'news' and 'rese...

  • Avatar

    ZACKS FYI...my ire is up about ZACK's because I strongly suspect they are trawling this website and pirating picks, whic...

  • Avatar

    $PVG $SSRI...ZACKS...another stupid thing that shows how superficial Zacks analysis is. They make a headline on SILVER, ...

  • Avatar

    ZACKS: what a joke. They publish some one-liner recruitment tags today pumping silver as an investment, and throw out ...

  • Avatar

    The analysts make me laugh. One sneezes and they all get a mild fever. They are all liking PVG now. Zacks suggested high...

  • SoGiAm

    #ZACKS - 4 Event Risks for the Rally a message from Reity and Kevin ($1 offer, Please understand that beyond $1 there i...

  • SoGiAm

    I am no longer a paying member of member of zacks. This is merely information that I am passing on to increase your aw...

  • Avatar

    Zacks rating on TRXC 3-Hold 3 Value: F | Growth: F | Momentum: F | VGM: F Be careful with TRXC. Like others ...

  • We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.

    More Info